LU-001i is a highly specific proteasome beta1i (LMP2) inhibitor. LU-001i alone has no significant immunomodulatory effect, but when combined with the LMP7 inhibitor (PRN1126), it can exert anti-inflammatory and immunomodulatory effects. LU-001i can be used for the study of autoimmune diseases[1].
Molecular Weight:
611.68
CAS Number:
[1620107-60-9]
Formula:
C28H43F2N7O6
Target:
Proteasome
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
